Adverum Biotechnologies logo
Adverum Biotechnologies ADVM

Quartalsbericht 2025-Q3
hinzugefügt 12.11.2025

report update icon

Adverum Biotechnologies Kurzfristige Verbindlichkeiten 2011-2026 | ADVM

Kurzfristige Verbindlichkeiten Jährlich Adverum Biotechnologies

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
22.9 M 20 M 32.2 M 21.3 M 20.9 M 19.4 M 10.7 M 10.7 M 9.9 M 6.57 M 5.47 M - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
32.2 M 5.47 M 16.4 M

Kurzfristige Verbindlichkeiten anderer Aktien in der Pharmaeinzelhändler

Name Kurzfristige Verbindlichkeiten Preis % 24h Marktkapitalisierung Land
Alnylam Pharmaceuticals Alnylam Pharmaceuticals
ALNY
1.19 B $ 322.7 0.84 % $ 41.2 B usaUSA
Acer Therapeutics Acer Therapeutics
ACER
19 M - 2.71 % $ 14 M usaUSA
Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc
ADAP
72.8 M - -15.15 % $ 60.3 M britainBritain
Amarin Corporation plc Amarin Corporation plc
AMRN
259 M $ 15.14 2.61 % $ 6.17 B irlandaIrlanda
Acasti Pharma Acasti Pharma
ACST
1.93 M - 4.01 % $ 150 M canadaCanada
I-Mab I-Mab
IMAB
576 M - - $ 866 M chinaChina
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
25.2 M - - $ 26.5 M usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
4.34 M $ 0.84 2.78 % $ 4.58 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
1.62 B - - $ 40.3 B usaUSA
Adagene Adagene
ADAG
38.2 M $ 2.95 10.57 % $ 166 M chinaChina
AlloVir AlloVir
ALVR
5.24 M - 4.14 % $ 49.1 M usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
1.77 M - -1.52 % $ 24.7 M usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
2.38 M - -11.43 % $ 502 K usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
15.1 M - - $ 10.1 M usaUSA
ARCA biopharma ARCA biopharma
ABIO
13 M - 1052.0 % $ 415 M usaUSA
Cabaletta Bio Cabaletta Bio
CABA
16 M $ 2.62 7.38 % $ 3.06 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
228 M - -24.86 % $ 820 K usaUSA
Compugen Ltd. Compugen Ltd.
CGEN
20.2 M $ 1.79 4.39 % $ 160 M israelIsrael
Akero Therapeutics Akero Therapeutics
AKRO
39.8 M - - $ 3.67 B usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
54.1 M - - $ 1.01 B usaUSA
Aptose Biosciences Aptose Biosciences
APTO
4.46 M - -45.71 % $ 1.2 M canadaCanada
Albireo Pharma Albireo Pharma
ALBO
45.3 M - -0.23 % $ 916 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
556 M - - - russiaRussia
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
15.7 M - 3.16 % $ 1.9 M usaUSA
Aptinyx Aptinyx
APTX
6.29 M - -39.0 % $ 4.57 M usaUSA
Aravive Aravive
ARAV
22.1 M - -13.39 % $ 1.45 M usaUSA
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
CORT
141 M $ 41.27 -0.1 % $ 4.26 B usaUSA
Catalyst Pharmaceuticals Catalyst Pharmaceuticals
CPRX
121 M $ 24.19 -1.06 % $ 2.87 B usaUSA
Arena Pharmaceuticals Arena Pharmaceuticals
ARNA
66.3 M - -6.81 % $ 3.04 B usaUSA
Champions Oncology Champions Oncology
CSBR
23.9 M $ 6.41 -2.14 % $ 87.6 M usaUSA
Aridis Pharmaceuticals Aridis Pharmaceuticals
ARDS
36.9 M - 17.91 % $ 11.1 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
5.91 M - -10.17 % $ 12.2 K usaUSA
Athira Pharma Athira Pharma
ATHA
13.1 M - - $ 269 M usaUSA
Athersys Athersys
ATHX
29.9 M - 3.77 % $ 22.4 M usaUSA
Akouos Akouos
AKUS
16.8 M - 0.23 % $ 488 M usaUSA
Avenue Therapeutics Avenue Therapeutics
ATXI
816 K - -52.27 % $ 4.45 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
2.05 M $ 4.54 7.58 % $ 9.88 B israelIsrael
Precision BioSciences Precision BioSciences
DTIL
50 M $ 3.77 -1.05 % $ 14.5 M usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
60.7 M $ 1.46 -0.34 % $ 373 M britainBritain
Amneal Pharmaceuticals Amneal Pharmaceuticals
AMRX
1.13 B $ 14.73 1.41 % $ 4.55 B usaUSA
Codexis Codexis
CDXS
23.6 M $ 1.27 -1.55 % $ 93.2 M usaUSA